Interestingly, these mammary tumors exhibited low expression levels of PRLR as well as other luminal and epithelial differentiation markers such as (Elf5, Muc1), claudins, and cell adhesion markers (Cdh1, Ocln), while showing elevated levels of EMT and BCSC markers. This evidence concerns the gene ELF5 and breast cancer.